Hostname: page-component-8448b6f56d-t5pn6 Total loading time: 0 Render date: 2024-04-19T04:10:52.264Z Has data issue: false hasContentIssue false

18Fluorodeoxyglucose Positron Emission Tomography Studies in Presumed Alzheimer Cases, Including 13 Serial Scans

Published online by Cambridge University Press:  18 September 2015

E.G. McGeer*
Affiliation:
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, Burnaby, British Columbia
R.P. Peppard
Affiliation:
Division of Neurology, Department of Medicine, Burnaby, British Columbia
P.L. McGeer
Affiliation:
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, Burnaby, British Columbia
H. Tuokko
Affiliation:
Department of Psychology, University Hospital, Burnaby, British Columbia
D. Crockett
Affiliation:
Division of Psychology, Department of Psychiatry, Burnaby, British Columbia
R. Parks
Affiliation:
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, Burnaby, British Columbia Division of Psychology, Department of Psychiatry, Burnaby, British Columbia
H. Akiyama
Affiliation:
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, Burnaby, British Columbia
D.B. Calne
Affiliation:
Division of Neurology, Department of Medicine, Burnaby, British Columbia
B.L. Beattie
Affiliation:
Department of Medicine, University of B.C., Burnaby, British Columbia
R. Harrop
Affiliation:
Vancouver, and School of Computer Science, Simon Fraser University, Burnaby, British Columbia
*
2255 Wesbrook Mall, University of B.C., Vancouver, British Columbia, Canada V6T 1W5
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Positron emission tomographic (PET) data on local cerebral metabolic rates for glucose (LCMR) are reported for 32 regions of interest (ROI)s in cross-sectional studies on 57 patients with clinically diagnosed Alzheimer's disease (AD) and 20 neurologically normal controls, and in serial studies on 13 of the AD cases, including a familial, young-onset case where the diagnosis has been confirmed at autopsy. Extensive psychological testing was done on all the AD cases. Almost all cortical regions showed a significant decline in LCMR with age in the control subjects. There were the expected cortical metabolic deficits in AD and the serial studies showed a general increase in such deficits over time in 12 of the 13 cases. The regions showing the greatest declines with time in serial studies are the same as those showing the most severe deficiencies in cross-sectional studies. The young-onset case did not show a greater rate of metabolic decline than many of the older cases studied. Results on individual psychological tests tended to correlate with metabolic rates in multiple, rather than single, cortical regions, suggesting intact neuronal networks are required for good performance. The correlations with cortical metabolic activity found were of a sign indicating that the higher the metabolic rates and the better the left:right asymmetry index, the better was the performance.

Type
Original Articles
Copyright
Copyright © Canadian Neurological Sciences Federation 1990

References

REFERENCES

1.McGeer, PL. Brain imaging in Alzheimer’s disease. Br Med Bull 1986; 42: 2428.CrossRefGoogle ScholarPubMed
2.Parks, RW, Crockett, DJ, McGeer, PL. Systems model of cortical organization: positron emission tomography and neuropsychological test performance. Arch Clin Neuropsych 1989; 4: (in press).CrossRefGoogle ScholarPubMed
3. McKhann, G, Drachman, D, Folstein, M, et al. Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer’s disease. Neurology 1984; 34: 939944.CrossRefGoogle ScholarPubMed
4.Sadovnick, AD, Tuokko, H, Horton, A, et al. Familial Alzheimer’s disease. Can J Neurol Sci 1989; 15: 142146.CrossRefGoogle Scholar
5.Crockett, D, Tuokko, H, Koch, W, et al. The assessment of everyday functioning using the present functioning questionaire and the functional rating scale in elderly samples. Clin Gerontol 1989; 8: 325.CrossRefGoogle Scholar
6.Tuokko, H, Crockett, D. Cued recall and memory disorders in dementia. J Clin Exp Neuropsychol 1989; 11: 278294.CrossRefGoogle ScholarPubMed
7.Martin, WRW, Beckman, JH, Calne, DB, et al. Cerebral glucose metabolism in Parkinson’s disease. Can J Neurol Sci 1984; 1: 169173.CrossRefGoogle Scholar
8.Hanaway, J, Scott, WR, Strother, CM. Atlas of the human brain and the orbit for computed tomography. St. Louis: WH Green 1980.Google Scholar
9.Phelps, ME, Huang, SC, Hoffman, EJ, et al. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979; 6: 371388.CrossRefGoogle ScholarPubMed
10.McGeer, PL, Kamo, H, Harrop, R, et al. Positron emission tomography in patients with clinically diagnosed Alzheimer’s disease. Can Med Assoc J 1986; 134: 597607.Google ScholarPubMed
11.Haxby, JV, Rapoport, SI. Abnormalities of regional brain metabolism in Alzheimer’s disease and their relation to functional impairment. Prog Neuro-Psychopharmacol & Biol Psychiatry 1986; 10: 427438.CrossRefGoogle ScholarPubMed
12.Jagust, WJ, Friedland, RP, Budinger, TF, et al. Longitudinal studiesof regional cerebral metabolism in Alzheimer’s disease. Neurology 1988; 38: 909912.CrossRefGoogle Scholar
13.Coval, M, Crockett, D, Holliday, S, et al. A multi-focus assessment scale for use with frail elderly populations. Can J Aging 1985; 4: 101109.CrossRefGoogle Scholar
14.Akiyama, H, Harrop, R, McGeer, PL, et al. Crossed cerebellar and uncrossed basal ganglia and thalamic diaschisis in Alzheimer’s disease. Neurology 1989; 39: 541548.CrossRefGoogle ScholarPubMed
15.Frackowiak, RSJ. Cerebral energy metabolism and blood flow in normal human ageing: a short review. Circulation et Metabolism du Cerveau 1987; 4: 8792.Google Scholar
16.Yoshii, F, Barker, WW, Chang, JY, et al. Sensitivity of cerebral glucose metabolism to age, gender, brain volume, brain atrophy, and cerebrovascular risk factors. J Cereb Blood Flow Metabol 1988; 8: 654661.CrossRefGoogle ScholarPubMed
17.deLeon, MJ, George, AE, Tomanelli, J, et al. Positron emission tomography studies of normal aging: a replication of PET III and 18-FDG using PET VI and 11-CDG. Neurobiol Aging 1987; 8: 319323.CrossRefGoogle Scholar
18.Rodriguez, G, Warkentin, S, Risberg, J, et al. Sex differences in regional cerebral blood flow. J Cereb Blood Flow Metabol 1988; 8: 783789.CrossRefGoogle ScholarPubMed
19.Tyler, JL, Strother, SC, Zatorre, RJ, et al. Stability of regional glucose metabolism in the normal brain measured by positron emission tomography. J Nucl Med 1988; 29: 631642.Google ScholarPubMed
20.Haxby, JV, Grady, CL, Koss, E, et al. Longitudinal study of brain metabolic and neuropsychological heterogeneity in dementia of the Alzheimer type: evidence for subtypes. J Cereb Blood Flow Metabol 1988; 7 (Suppl 1): S377.Google Scholar
21.Friedland, RP, Budinger, TF, Koss, E, et al. Alzheimer’s disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neurosci Lett 1985; 53: 235240.CrossRefGoogle ScholarPubMed
22.Cutler, NR, Haxby, JV, Duara, R, et al. Brain metabolism as measured with positron emission tomography: serial assessment in a patient with familial Alzheimer’s disease. Neurology 1985; 35: 15561561.CrossRefGoogle Scholar
23.Lenzi, GL, Gibbs, JM, Frackowiak, RSJ, et al. Measurement of cerebral blood flow and oxygen metabolism by positron emission tomography and the l50 steady-state technique: aspects of methodology, reproducibility and clinical application. In: Magistretti, PL, ed. Functional Radionuclide Imaging of the Brain, New York, Raven Press, 1983; 291309.Google Scholar
24.Bartlett, EJ, Brodie, JD, Wolf, AP, et al. Reproducibility of cerebral glucose metabolic measurements in resting human subjects. J Cereb Blood Flow Metabol 1988; 8: 502512.CrossRefGoogle ScholarPubMed
25.Grady, CL, Haxby, JV, Schlageter, NL, et al. Stability of metabolic and neuropsychological asymmetries in dementia of the Alzheimer type. Neurology 1986; 36: 13901392.CrossRefGoogle ScholarPubMed
26.Grady, CL, Haxby, JV, Horwitz, B, et al. Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. J Clin Exp Neuropsychol 1988; 10: 576596.CrossRefGoogle ScholarPubMed
27.Szelies, B, Herholz, K, Pawlik, G, et al. Cerebral glucose metabolism in presenile dementia (Alzheimer’s disease) — follow-up under treatment course with a muscarinic choline agonist. Fortschr Neurol Psychiatry 1986; 54: 364373.CrossRefGoogle Scholar
28.Jamieson, DG, Chawluk, JB, Alavi, A, et al. The effect of disease seventy on local cerebral glucose metabolism in Alzheimer’s disease. J Cereb Blood Flow Metabol 1987; 7 (Suppl 1): S410.Google Scholar
29.Friedland, RP, Jagust, WJ, Budinger, TF, et al. Consistency of temporal-parietal cortex hypometabolism in probable Alzheimer’s disease (AD): relationship to cognitive decline. J Cereb Blood Flow Metabol 1987; 7 (Suppl 1): S403.Google Scholar
30.Duara, R, Grady, C, Haxby, J, et al. Positron emission tomography in Alzheimer’s disease. Neurology 1986; 36: 879887.CrossRefGoogle ScholarPubMed
31.Loewenstein, D, Yoshii, F, Barker, WW, et al. Predominant left hemisphere metabolic deficit predicts early manifestation of dementia. J Cereb Blood How Metabol 1987; 7 (Suppl 1): S416.Google Scholar
32.Friedland, RP, Brun, A, Budinger, TF. Pathological and positron emission tomography correlations in Alzheimer’s disease. Lancet 1985i: 228.CrossRefGoogle ScholarPubMed
33.McGeer, PL, Kamo, H, Harrop, R, et al. Comparison of PET, MRI and CT with pathology in a proven case of Alzheimer’s disease. Neurology 1986; 36: 15691574.CrossRefGoogle Scholar